Juan Francisco V. C.
- Country
- Spain
- Department
- Neurology
Research Overview
- Multiple Ascending Dose Evaluation of LY4256984 in Patients with Sporadic Amyotrophic Lateral Sclerosis
- A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Usnoflast in Adults with Amyotrophic Lateral Sclerosis
- Phase 1/2 Study to Evaluate the Safety and Tolerability of VTx-002 in Patients with Amyotrophic Lateral Sclerosis
Data & Insights
Has run more than one trial at 48 of 90 partner sites.
Specializations
Neurodegenerative Disease Research
This investigator specializes in the study of amyotrophic lateral sclerosis (ALS), conducting extensive research into various therapeutic approaches for this condition. Their work encompasses both general ALS populations and specific genetic variants.
- Progressive Motor Neuron Disease Management
- Disease Progression Assessment
- Genetic ALS Variants
Their research includes evaluating novel therapeutic compounds targeting different aspects of ALS pathology.
Neuromuscular Disorders
The investigator focuses on spinal muscular atrophy (SMA), particularly investigating therapeutic interventions for various types of the condition. Their work includes assessment of muscle strength and function in SMA patients.
- Type 3 SMA Treatment
- Drug Delivery Systems
- Functional Outcome Measures
Their research extends to innovative drug administration methods and their effects on treatment outcomes.
Clinical Assessment Methods
The investigator develops and implements clinical evaluation protocols for neurological conditions, focusing on survival metrics and functional assessments.
- Ventilation-Free Survival Assessment
- Biomarker Analysis
- Treatment Response Monitoring
Their work includes evaluation of both traditional and novel assessment methodologies in neurodegenerative conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.